Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics DifferentlyNazar Farid, Daniel E. Salazar, Christopher D. Payne et al.|Clinical Pharmacology & Therapeutics|2007Cited by 323
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose ClopidogrelChristopher D. Payne, Kenneth J. Winters, David S. Small et al.|Journal of Cardiovascular Pharmacology|2007Cited by 167
Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy SubjectsNagy A. Farid, Kenneth J. Winters, David S. Small et al.|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2008Cited by 87
Inhibition of platelet aggregation with prasugrel and clopidogrel: An integrated analysis in 846 subjectsYing G. Li, Kenneth J. Winters, Lan Ni et al.|Platelets|2009Cited by 61
Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjectsNazar Farid, D. S. Small, Christopher D. Payne et al.|Current Medical Research and Opinion|2009Cited by 34